Wedbush Reviews Fennec Pharmaceuticals' Q4

In This Article:

Fennec Pharmaceuticals' fourth-quarter Pedmark revenue of US$7.9 million beat Wedbush's US$7.6 milli

Upgrade to read this MT Newswires article and get so much more.
A Silver or Gold subscription plan is required to access premium news articles.